Purpose–This paper seeks to address the value relevance of summary accounting
measures and fundamental income statement variables in the market valuation of biotech …

Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …

Understanding the social processes that support innovations in new biotechnologies
presents an interesting challenge. Evidence from the Australian bioindustry reveals how the …

The biotechnology industry offers an exciting context to analyze how organizations are able
to manage two different but complementary issues: the ability to search for new knowledge …

Regulation is a necessary part of life sciences as it ensures product quality and patient
safety. The Food and Drug Administration (FDA) is the regulatory agency which facilitates …

Genetically modified products have gradually entered people's life because of the rapid
development of biotechnology. With the perfection and progress of relevant technologies …

Bioentrepreneurship is a biological entity related to sciences that creates, builds, and
acquires profit to establish a business. At present, the biggest challenges for …

Using the resource-based view as theoretical background, the authors analyse the
technology sourcing process of 77 cooperation projects in biotechnology. Trust and …

Alliances between big pharmaceutical firms (BPF) and smaller biotechnology firms (BIOF)
are increasing. The 20 largest BPF firms formed nearly 1,500 alliances with BIOFs between …